Mrs. Britt Marie Lewis, MA, CCC/SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 2903 E 25th Ave, Spokane, WA 99223 Phone: 509-536-6650 |
Jessie Rae Johnson, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 101 W 8th Ave, Spokane, WA 99204 Phone: 509-474-3131 |
Kadie Langford, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1001 E Montgomery Ave, Spokane, WA 99207 Phone: 509-354-3458 |
Lindsay Anne Williams, CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 711 S Cowley St, Spokane, WA 99202 Phone: 509-473-6000 |
Mrs. Teri W Morrison, M.S.CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 711 S Cowley St, Spokane, WA 99202 Phone: 509-838-4771 |
Michael Ward Laycock Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 5717 S Chaperon Peak Ct, Spokane, WA 99224 Phone: 509-413-6411 |
Mrs. Carol Lynn Reeves, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8818 E Grace Ave, Spokane, WA 99212 Phone: 509-922-5478 |
Kristin Leonora Joham, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 N Bernard St, Spokane, WA 99201 Phone: 509-354-5400 |
Elizabeth Aileen Hartnett, SP/L Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2118 W Garland Ave, Spokane, WA 99205 Phone: 509-326-1651 Fax: 509-326-1658 |
Kristine Marshall, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7407 N Division St, Suite B, Spokane, WA 99208 Phone: 509-448-9358 Fax: 509-448-5973 |
Alicia Aldendorf, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2707 E Rich Ave, Spokane, WA 99207 Phone: 509-999-2705 |
Ms. Ashley Potter, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1403 S Grand Blvd, Suite 203s, Spokane, WA 99203 Phone: 509-835-4404 Fax: 509-835-4400 |
Jennifer Forim, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8502 N Nevada St # 2, Spokane, WA 99208 Phone: 509-487-2958 Fax: 509-487-3025 |
Norton Speech & Voiceworks Pllc Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 4407 N Division St, Suite 618, Spokane, WA 99207 Phone: 509-279-2555 |
Jennine Ann Sprangers Fitzgerald, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4815 N Assembly St, Spokane, WA 99205 Phone: 509-434-7065 |
Elizabeth Ann Pirttima, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2118 W Garland Ave, Spokane, WA 99205 Phone: 509-326-1651 Fax: 509-326-1658 |
Samantha Salzwedel, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 709 E 37th Ave, Spokane, WA 99203 Phone: 208-413-4431 |
Leslie Haupt Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 N Bernard St, Spokane, WA 99201 Phone: 509-354-3231 |
Patricia Jill Bliss Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 711 S Cowley St, Spokane, WA 99202 Phone: 509-473-6000 |
Donna Jane Stoyko, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: St. Lukes Rehab., 711 S. Cowley, Spokane, WA 99202 Phone: 509-473-6000 |
News Archive
VisualSonics Inc., a leader in real time, in vivo, high-resolution micro-imaging systems and a wholly-owned subsidiary of SonoSite Inc., is demonstrating the recently announced Vevo LAZR Photoacoustics Imaging system at the American Association of Cancer Research's annual conference.
The study conducted by Dr Richard Stephens, from Keele University, and David Spierer and Emmanuel Katehis, from Long Island University Brooklyn, reveals that swearing aloud makes individuals stronger.
Late last year, the Food and Drug Administration proposed sensible regulations that would authorize the makers of generic drugs to update safety labels independently, without waiting for F.D.A. approval, to warn of newly discovered risks.
Targacept, Inc., a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR Therapeutics, today confirmed plans to present data from its completed Phase 2b clinical trial of TC-5214 as an augmentation treatment for major depressive disorder at the Nicotinic Acetylcholine Receptors as Therapeutic Targets Symposium (nAChR2009) in Lincolnshire, Illinois on October 15, 2009.
Excessive fear can develop after a traumatic experience, leading to anxiety disorders such as post-traumatic stress disorder and phobias. During exposure therapy, an effective and common treatment for anxiety disorders, the patient confronts a fear or memory of a traumatic event in a safe environment, which leads to a gradual loss of fear.
› Verified 3 days ago